Why the study?
What is the incidence of adverse effects associated with enalapril in a postmarketing surveillance cohort?
What is the incidence of adverse effects associated with enalapril in a postmarketing surveillance cohort?
Postmarketing surveillance of enalapril over one year confirms its safety profile, with common adverse effects being dizziness and dry cough, and no deaths directly attributed to the drug.
Authors
No takes yet. Share an insight, caveat, or question.
Reassures on enalapril tolerability in routine care; leaves open need for randomized confirmation of rare risks in renal impairment.
Inman et al. (1988) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: